This company listing is no longer active
Nabriva Therapeutics Salute del bilancio
Salute finanziaria criteri di controllo 0/6
Nabriva Therapeutics has a total shareholder equity of $-16.3M and total debt of $540.0K, which brings its debt-to-equity ratio to -3.3%. Its total assets and total liabilities are $10.6M and $26.9M respectively.
Informazioni chiave
-3.3%
Rapporto debito/patrimonio netto
US$540.00k
Debito
| Indice di copertura degli interessi | n/a |
| Contanti | US$2.18m |
| Patrimonio netto | -US$16.32m |
| Totale passività | US$26.90m |
| Totale attività | US$10.58m |
Aggiornamenti recenti sulla salute finanziaria
Recent updates
Analisi della posizione finanziaria
Passività a breve termine: NTY has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Passività a lungo termine: NTY has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: NTY has negative shareholder equity, which is a more serious situation than a high debt level.
Riduzione del debito: NTY's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Bilancio
Analisi della pista di contanti
Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.
Pista di liquidità stabile: NTY has less than a year of cash runway based on its current free cash flow.
Previsione Cash Runway: NTY has less than a year of cash runway if free cash flow continues to grow at historical rates of 10% each year.